Published in Ann Thorac Surg on October 01, 2007
Outcomes of Thoracic Endovascular Aortic Repair and Subclavian Revascularization Techniques. J Am Coll Surg (2015) 2.10
Evolution of aortic arch repair. Tex Heart Inst J (2009) 0.87
Thoracic endovascular aortic repair with left subclavian artery coverage without prophylactic revascularisation-early and midterm results. Langenbecks Arch Surg (2014) 0.77
Experience of endovascular repair of thoracic aortic dissection after blunt trauma injury in a district general hospital. J Thorac Dis (2016) 0.75
Thoracic endovascular aortic repair with the chimney technique for blunt traumatic pseudoaneurysm of the aortic arch in a no-option patient. Yonsei Med J (2013) 0.75
Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med (2006) 13.51
Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med (2013) 8.91
Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med (2014) 7.23
Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med (2013) 6.21
Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation (2009) 3.75
Does the addition of glutamine to enteral feeds affect patient mortality? Crit Care Med (2005) 3.43
Blood transfusion and infection after cardiac surgery. Ann Thorac Surg (2013) 3.35
Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation. N Engl J Med (2015) 3.11
Central cannulation is safe in acute aortic dissection repair. J Thorac Cardiovasc Surg (2006) 2.98
The role of methylene blue in serotonin syndrome following cardiac transplantation: a case report and review of the literature. J Thorac Cardiovasc Surg (2012) 2.86
Surgical ventricular restoration in the treatment of congestive heart failure due to post-infarction ventricular dilation. J Am Coll Cardiol (2004) 2.62
Splenic artery aneurysms: two decades experience at Mayo clinic. Ann Vasc Surg (2002) 2.51
Hepatic artery aneurysm: factors that predict complications. J Vasc Surg (2003) 2.50
Early outcomes using the Florida sleeve repair for correction of aortic insufficiency due to root aneurysms. Ann Thorac Surg (2009) 2.24
The spectrum, management and clinical outcome of Ehlers-Danlos syndrome type IV: a 30-year experience. J Vasc Surg (2005) 2.19
RIFLE criteria for acute kidney injury in aortic arch surgery. J Thorac Cardiovasc Surg (2007) 2.17
Predicted risk of mortality models: surgeons need to understand limitations of the University HealthSystem Consortium models. J Am Coll Surg (2009) 2.10
Does the Society of Thoracic Surgeons risk score accurately predict operative mortality for patients with pulmonary hypertension? J Thorac Cardiovasc Surg (2012) 2.09
Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome. Ann Thorac Surg (2002) 1.91
Contemporary management of acute mesenteric ischemia: Factors associated with survival. J Vasc Surg (2002) 1.90
Carotid endarterectomy in SAPPHIRE-eligible high-risk patients: implications for selecting patients for carotid angioplasty and stenting. J Vasc Surg (2004) 1.82
Alveolar macrophage activation is a key initiation signal for acute lung ischemia-reperfusion injury. Am J Physiol Lung Cell Mol Physiol (2006) 1.80
The United States Registry for Fibromuscular Dysplasia: results in the first 447 patients. Circulation (2012) 1.75
Intrathoracic vacuum-assisted management of persistent and infected pleural spaces. Ann Thorac Surg (2010) 1.74
Ex vivo rehabilitation of non-heart-beating donor lungs in preclinical porcine model: delayed perfusion results in superior lung function. J Thorac Cardiovasc Surg (2012) 1.73
Primary payer status affects mortality for major surgical operations. Ann Surg (2010) 1.69
Do you need to clamp a patent left internal thoracic artery-left anterior descending graft in reoperative cardiac surgery? Ann Thorac Surg (2009) 1.63
Cost-analysis of percutaneous pulmonary valve implantation compared to surgical pulmonary valve replacement. Catheter Cardiovasc Interv (2013) 1.53
Smooth muscle phenotypic modulation is an early event in aortic aneurysms. J Thorac Cardiovasc Surg (2009) 1.53
High spatial resolution magnetic resonance imaging of cystic adventitial disease of the popliteal artery. J Vasc Surg (2010) 1.52
Is mitral valve repair superior to replacement in elderly patients? Ann Thorac Surg (2008) 1.52
Percutaneous intentional extraluminal recanalization in patients with chronic critical limb ischemia. Radiology (2004) 1.51
Sleep deprivation does not affect operative results in cardiac surgery. Ann Thorac Surg (2004) 1.51
Motor and somatosensory evoked potentials: their role in predicting spinal cord ischemia in patients undergoing thoracoabdominal aortic aneurysm repair with regional lumbar epidural cooling. Anesthesiology (2008) 1.50
Coronary artery bypass with ventricular restoration is superior to coronary artery bypass alone in patients with ischemic cardiomyopathy. J Thorac Cardiovasc Surg (2004) 1.50
MR imaging of soft-tissue vascular malformations: diagnosis, classification, and therapy follow-up. Radiographics (2011) 1.48
Proinflammatory response of alveolar epithelial cells is enhanced by alveolar macrophage-produced TNF-alpha during pulmonary ischemia-reperfusion injury. Am J Physiol Lung Cell Mol Physiol (2007) 1.48
Is off-pump coronary artery bypass grafting superior to conventional bypass in octogenarians? J Thorac Cardiovasc Surg (2010) 1.47
Surgical management of descending thoracic aortic disease: open and endovascular approaches: a scientific statement from the American Heart Association. Circulation (2010) 1.47
Superior mesenteric artery aneurysms: is presence an indication for intervention? J Vasc Surg (2002) 1.46
Blood product conservation is associated with improved outcomes and reduced costs after cardiac surgery. J Thorac Cardiovasc Surg (2013) 1.45
Endovascular repair of abdominal aortic aneurysms: initial experience with 100 consecutive patients. Mayo Clin Proc (2003) 1.44
Comparison of systemic and retrograde delivery of adenosine A2A agonist for attenuation of spinal cord injury after thoracic aortic cross-clamping. Ann Thorac Surg (2006) 1.44
Additive protection against lung ischemia-reperfusion injury by adenosine A2A receptor activation before procurement and during reperfusion. J Thorac Cardiovasc Surg (2007) 1.42
Replacement of the proximal aorta adds no further risk to aortic valve procedures. Ann Thorac Surg (2007) 1.40
Mitral stenosis caused by an amplatzer occluder device used to treat a paravalvular leak. Ann Thorac Surg (2012) 1.39
Caring for the residents: the view of two program directors. Ann Thorac Surg (2004) 1.38
Outcomes of patients with acute upper gastrointestinal nonvariceal hemorrhage referred to interventional radiology for potential embolotherapy. J Clin Gastroenterol (2014) 1.38
Surgical ventricular restoration: the RESTORE Group experience. Heart Fail Rev (2004) 1.37
Iatrogenic hepatic artery pseudoaneurysms: an uncommon complication after hepatic, biliary, and pancreatic procedures. Ann Vasc Surg (2003) 1.36
Natural killer T cell-derived IL-17 mediates lung ischemia-reperfusion injury. Am J Respir Crit Care Med (2011) 1.35
Current results of open revascularization for chronic mesenteric ischemia: a standard for comparison. J Vasc Surg (2002) 1.29
The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. J Vasc Interv Radiol (2005) 1.28
CD4+ T lymphocytes mediate acute pulmonary ischemia-reperfusion injury. J Thorac Cardiovasc Surg (2009) 1.28
Open surgical and endovascular treatment of superior vena cava syndrome caused by nonmalignant disease. J Vasc Surg (2003) 1.26
Quantitative trait locus analysis of atherosclerosis in an intercross between C57BL/6 and C3H mice carrying the mutant apolipoprotein E gene. Genetics (2005) 1.24
Circulating adhesion molecules in apoE-deficient mouse strains with different atherosclerosis susceptibility. Biochem Biophys Res Commun (2005) 1.24
Takayasu's arteritis: operative results and influence of disease activity. J Vasc Surg (2006) 1.22
Adenosine A2A receptor activation reduces inflammation and preserves pulmonary function in an in vivo model of lung transplantation. J Thorac Cardiovasc Surg (2005) 1.22
Orthotopic heart transplant versus left ventricular assist device: a national comparison of cost and survival. J Thorac Cardiovasc Surg (2012) 1.18
Endoscopic versus open saphenous vein harvest for femoral to below the knee arterial bypass using saphenous vein graft. J Vasc Surg (2006) 1.18
Adenosine A2A receptor activation on CD4+ T lymphocytes and neutrophils attenuates lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg (2009) 1.17
Optimal surgical management of severe ischemic mitral regurgitation: to repair or to replace? J Thorac Cardiovasc Surg (2011) 1.17
Penetrating atherosclerotic ulcer of the descending thoracic aorta and arch. J Thorac Cardiovasc Surg (2004) 1.17
Simultaneous antegrade and retrograde access for subintimal recanalization of peripheral arterial occlusion. J Vasc Interv Radiol (2003) 1.16
Pretreatment strategy with adenosine A2A receptor agonist attenuates reperfusion injury in a preclinical porcine lung transplantation model. J Thorac Cardiovasc Surg (2011) 1.16
Outcomes of surgical aortic valve replacement in high-risk patients: a multiinstitutional study. Ann Thorac Surg (2011) 1.14
Incidence and management of inferior vena cava filter thrombus detected at time of filter retrieval. J Vasc Interv Radiol (2011) 1.14
The role of adenosine A2A receptor signaling in bronchiolitis obliterans. Ann Thorac Surg (2009) 1.13